Advertisement
Loading...

Novartis AG

NVS•NYSE
Healthcare
Drug Manufacturers - General
$148.08
$-1.69(-1.13%)
U.S. Market opens in 26h 56m

Novartis AG (NVS) Stock Overview

Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap282.5B
P/E Ratio20.87
EPS (TTM)$6.98
ROE0.32%
Fundamental Analysis

AI Price Forecasts

1 Month$151.91
3 Months$188.44
1 Year Target$163.60

NVS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novartis AG (NVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.04, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $163.60.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.87 and a market capitalization of 282.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.14%
5-Day Change
1.10%
1-Month Change
-2.64%
3-Month Change
-9.22%
6-Month Change
12.80%
Year-to-Date (YTD) Change
7.39%
1-Year Change
36.51%
3-Year Change
51.73%
5-Year Change
76.70%
All-Time (Max) Change
841.26%

Contact Information

https://www.novartis.com
41 61 324 1111
Lichtstrasse 35, Basel, NaN, 4056

Company Facts

75,883 Employees
IPO DateNov 7, 1996
CountryCH
Actively Trading

Frequently Asked Questions